West Lake Award · The most popular corporate brand in the pharmacy announced in Wuzhen

On June 27, the 2022 China Big Health Industry Forum officially opened at Wuzhen Internet International Convention and Exhibition Center. The theme of this forum is "high -quality development to the future", gathered experts, enterprises, chains, industry elites, etc., to jointly explore the innovative development and cooperation path of the large health industry in the era of the bureau.

On the 28th, this forum announced the "West Lake Award · The Most Welcome Enterprise Brand" award. Welcome corporate brand.

It is understood that the combination of Ling Pharmaceutical's research with the theory of iverology and modern clinical applications has been combined, and the system has established a theoretical system of neat disease, becoming the company's unique core competitiveness of science and technology.

Focusing on the theoretical research of linked disease, Ling Pharmaceuticals has undertaken and completed the National 973, 863, National "Eleventh Five -Year Plan" support, the creation of major new drugs in the national "12th Five -Year Plan", and the national major national projects. The research results have been recognized by the country and industry. Among them, the "Construction of Traditional Chinese Medicine Polarization and the Prevention of Micromiors Diseases" project won the first prize of national science and technology progress in 2019. This is the only first national scientific and technological progress prize in the field of medical and health in my country.

The innovative patent traditional Chinese medicine developed under the theory of collateral disease covers major diseases such as cardiovascular and cerebrovascular diseases, respiratory diseases, tumors, diabetes and other major diseases, and formed Tongxin Loos Capsules, Ginseng Yang Xinxin Capsules, Qiqian Qiangxin Capsules, A number of effective drugs for cardiovascular and cerebrovascular diseases and diabetes for cardiovascular and cerebrovascular diseases, and cardiovascular and cerebrovascular disease drugs are leading positions in the industry. Tens of millions of people have benefited each year and benefit people's health.

- END -